David J. Sutton

Stoke-on-trent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Use of andexanet alfa: A British Society for Haematology position statement.

Use of andexanet alfa: A British Society for Haematology position statement.

Journal: British journal of haematology
Published: February 10, 2026

Safety of and serological response to a new canine distemper-parvovirus combination vaccine in domestic ferrets.

Safety of and serological response to a new canine distemper-parvovirus combination vaccine in domestic ferrets.

Journal: The Veterinary record
Published: June 07, 2025

Assessing Canine Parvovirus Vaccine Performance in Puppies with Maternally Derived Antibody: An Improved Study Design.

Assessing Canine Parvovirus Vaccine Performance in Puppies with Maternally Derived Antibody: An Improved Study Design.

Journal: Vaccines
Published: May 09, 2025

Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies.

Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies.

Journal: Thrombosis research
Published: November 23, 2024

Fatal drug reaction to andexanet alfa: a case report.

Fatal drug reaction to andexanet alfa: a case report.

Journal: EJHaem
Published: April 16, 2024

Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.

Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.

Journal: Journal of thrombosis and thrombolysis
Published: January 04, 2024

Understanding the disease and economic impact of avirulent avian paramyxovirus type 1 (APMV-1) infection in Great Britain.

Understanding the disease and economic impact of avirulent avian paramyxovirus type 1 (APMV-1) infection in Great Britain.

Journal: Epidemiology and infection
Published: August 25, 2023

Development of a Novel Canine Parvovirus Vaccine Capable of Stimulating Protective Immunity in Four-Week-Old Puppies in the Face of High Levels of Maternal Antibodies.

Development of a Novel Canine Parvovirus Vaccine Capable of Stimulating Protective Immunity in Four-Week-Old Puppies in the Face of High Levels of Maternal Antibodies.

Journal: Vaccines
Published: August 09, 2023

Game Birds Can Act as Intermediaries of Virulent Genotype VII Avian Orthoavulavirus-1 between Wild Birds and Domestic Poultry.

Game Birds Can Act as Intermediaries of Virulent Genotype VII Avian Orthoavulavirus-1 between Wild Birds and Domestic Poultry.

Journal: Viruses
Published: January 25, 2023

How will UK hospitals use andexanet alfa? A review of local protocols.

How will UK hospitals use andexanet alfa? A review of local protocols.

Journal: EJHaem
Published: December 16, 2022

Comparative pathogenesis of two genotype VI.2 avian paramyxovirus type-1 viruses (APMV-1) in pheasants, partridges and chickens.

Comparative pathogenesis of two genotype VI.2 avian paramyxovirus type-1 viruses (APMV-1) in pheasants, partridges and chickens.

Journal: Avian pathology : journal of the W.V.P.A
Published: October 07, 2022

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices.

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices.

Journal: Blood advances
Published: August 30, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026